Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Rapid Diagnostic Tests versus Clinical Diagnosis for Managing People with Fever in Malaria Endemic Settings

About this resource:

Systematic review

Source: The Cochrane Collaborative

Last Reviewed: April 2014

Workgroups: Global Health Workgroup

In this Cochrane systematic review, the Cochrane Collaborative found that using rapid diagnostic tests rather than symptom reports alone to diagnose malaria had little effect on the number of people still feeling sick 4 to 7 days after treatment. However, researchers found that using these tests did result in fewer prescriptions for antimalarial drugs. The reduction was highest when health workers only prescribed antimalarials after a positive test, and where malaria was less common.

Read more about this resource

Objectives related to this resource (1)

Increase laboratory diagnostic testing capacity, surveillance, and reporting globally — GH‑D03
Developmental

Suggested Citation

1.

Odaga, J., Sinclair, D., Lokong, J. A., Donegan, S., Hopkins, H., & Garner, P. (2014). Rapid diagnostic tests versus clinical diagnosis for managing people with fever in malaria endemic settings. Cochrane Database of Systematic Reviews, 2014 (4). DOI: 10.1002/14651858.CD008998.pub2.